SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: yosi s who wrote (316)12/9/1998 7:48:00 PM
From: crysball  Read Replies (1) | Respond to of 1386
 
Bright Side......Robert Cook

While the news is dated by a few days..........the November Insider Trading shows Robert Cook continues to make small (but consistent) buys of PARS stock.



To: yosi s who wrote (316)1/3/1999 10:18:00 PM
From: BRAVEHEART  Read Replies (2) | Respond to of 1386
 
Hi yosi s,

Could you describe to me what sort of conversion process is PARS under? How much and at what rate? I also noticed there is little cash. How much in revenues does PARS anticipate over the next year? How does one arrive at conservative yet realistic figures. Is it likely for PARS to draw down more with its convertible financing? What sort of partnering or collaborations are anticipated over the next year?

LONE WOLF


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News